Stay informed about the latest updates and insights from the Conscio Group, the group of companies dedicated to improving health worldwide through quality science.

  • 2 October 2024

    Conscio Group and Kiel Labs Announce Strategic Partnership

    Conscio Group, a European network of GMP/GLP/GCP/IEC-certified contract R&D service providers, and Kiel Laboratories, Inc., a leading U.S. pharmaceutical research and development company, today announced a strategic partnership to enhance drug development capabilities and market access for their respective clients.

  • 4 September 2024

    Meet us at the heart of Pharma at CPHI 2024

    Conscio Group is attending CPHI 2024 in Milan, Italy.

  • 10 June 2024

    Vorteile sequentieller Designs in Bioäquivalenzstudien

    Entdecken Sie die Leistungsfähigkeit sequentieller Designs für Bioäquivalenzstudien, einem entscheidenden Schritt in der Entwicklung von Generika: Ihre praktische Umsetzung, statistische Analyse und das Wohlbefinden der Freiwilligen.

  • 14 May 2024

    A new partnership with Reference Analytics GmbH

    The Conscio Group is expanding its range of services in Austria by acquiring Reference Analytics GmbH.

  • 4 December 2023

    Our new clinical unit in Ostrava (CZ) comes to life

    It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava (CZ) with 36-beds capacity has been opened.

  • 18 July 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new breast cancer treatment.

  • 4 July 2023

    Microbiology and Batch Testing: Bridging Across Sectors

    Discover LVA GmbH and EL Labs s.r.o., the only Conscio Group subsidiaries at the intersection of our Pharma and Nutrition end-to-end solutions.

  • 28 June 2023

    EL Labs: Celebrating 30 Years of Analytical Milestones

    Join Ján Šteso, CEO of EL Labs, as we celebrate our team's dedication, challenges overcome, and key milestones in EL's evolution.

  • 22 June 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

  • 15 June 2023

    Novavax & Conscio: Behind the Scenes of Vaccine Development

    Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.